Ken Griffin ENLIVEN THERAPEUTICS INC Transaction History

Citadel Advisors LLC

  • $618 Billion
  • Q3 2025
Number of Shares
1,160,503
Previous 1,470,424 21.08%
Holding current value
$0
Previous $0 NaN%
% of portfolio
0.0%
Previous 0.0%

Shares

10 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 14, 2025
SELL
N/A
-309,921 Reduced 21.08%
1,160,503 $0
Q2 2025

Aug 14, 2025
BUY
N/A
347,286 Added 30.92%
1,470,424 $0
Q1 2025

May 15, 2025
SELL
N/A
-615,394 Reduced 35.4%
1,123,138 $0
Q4 2024

Feb 14, 2025
BUY
N/A
4,555 Added 0.26%
1,738,532 $0
Q3 2024

Nov 14, 2024
SELL
N/A
-573,837 Reduced 24.86%
1,733,977 $0
Q2 2024

Aug 14, 2024
SELL
N/A
-46,589 Reduced 1.98%
2,307,814 $0
Q1 2024

May 15, 2024
SELL
N/A
-40,045 Reduced 1.67%
2,354,403 $0
Q4 2023

Feb 14, 2024
BUY
N/A
42,957 Added 1.83%
2,394,448 $0
Q3 2023

Nov 14, 2023
BUY
N/A
55,281 Added 2.41%
2,351,491 $0
Q1 2023

May 15, 2023
BUY
N/A
2,296,210 New
2,296,210 $0
Track Ken Griffin's Portfolio

Track Ken Griffin Portfolio

Follow Ken Griffin (Citadel Advisors LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email